Join
Live feed
·
PRReleasevia Quantisnow
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

ByQuantisnow·Wall Street's wire, on your screen.
TNXP· Tonix Pharmaceuticals Holding Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNXP (Tonix Pharmaceuticals Holding Corp.) and more on Quantisnow.